Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2021

Open Access 01-12-2021 | Aortic Valve Replacement | Research article

Natural history observations in moderate aortic stenosis

Authors: Yu Du, Mario Gössl, Santiago Garcia, Maurice Enriquez-Sarano, Joao L. Cavalcante, Richard Bae, Go Hashimoto, Miho Fukui, Bernardo Lopes, Aisha Ahmed, Christian Schmidt, Larissa Stanberry, Ross Garberich, Steven M. Bradley, Robert Steffen, Paul Sorajja, MD

Published in: BMC Cardiovascular Disorders | Issue 1/2021

Login to get access

Abstract

Background

The natural history of patients with moderate aortic stenosis (AS) is poorly understood. We aimed to determine the long-term outcomes of patients with moderate AS.

Methods

We examined patients with moderate AS defined by echocardiography in our healthcare system, and performed survival analyses for occurrence of death, heart failure (HF) hospitalization, and progression of AS, with accounting for symptoms, left ventricular dysfunction, and comorbidities.

Results

We examined 729 patients with moderate AS (median age, 76 years; 59.9 % men) with a median follow-up of 5.0 years (interquartile range: 2.0 to 8.1 years). The 5-year overall survival was 52.3 % (95 % confidence interval [CI]: 48.6 % to 56.0 %) and survival free of death or HF hospitalization was 43.2 % (95 % CI: 39.5 % to 46.9 %). Worse New York Heart Association (NYHA) functional class was associated with poor long-term survival, with mortality rates ranging from 7.9 % (95 % CI: 6.6–9.2 %) to 25.2 % (95 % CI: 20.2–30.3 %) per year. Among patients with minimal or no symptoms, no futility markers, and preserved left ventricular function, 5-year overall survival was 71.9 % (95 % CI: 66.4–77.4 %) and survival free of death or HF hospitalization was 61.4 % (95 % CI: 55.5–67.3 %). Risk factors associated with adverse events were age, NYHA class, low ejection fraction and high aortic valve velocity (all p < 0.05).

Conclusions

Patients with moderate AS are at significant risk of death. Our findings highlight the need for more study into appropriate therapeutic interventions to improve the prognosis of these patients.
Appendix
Available only for authorised users
Literature
1.
go back to reference Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet (Lond, Engl). 2006;368:1005–11.CrossRef Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet (Lond, Engl). 2006;368:1005–11.CrossRef
2.
go back to reference Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, O’Gara PT, Ruiz CE, Skubas NJ, Sorajja P, Sundt TM 3rd, Thomas JD. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll&nbsp; Cardiol. 2014;63:2438–88.CrossRef Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, O’Gara PT, Ruiz CE, Skubas NJ, Sorajja P, Sundt TM 3rd, Thomas JD. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll&nbsp; Cardiol. 2014;63:2438–88.CrossRef
3.
go back to reference Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, Iung B, Lancellotti P, Lansac E, Rodriguez Munoz D, Rosenhek R, Sjogren J, Tornos Mas P, Vahanian A, Walther T, Wendler O, Windecker S, Zamorano JL. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017;38:2739–91.CrossRef Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, Iung B, Lancellotti P, Lansac E, Rodriguez Munoz D, Rosenhek R, Sjogren J, Tornos Mas P, Vahanian A, Walther T, Wendler O, Windecker S, Zamorano JL. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017;38:2739–91.CrossRef
4.
go back to reference 4, Lancellotti P, Magne J, Dulgheru R, Clavel MA, Donal E, Vannan MA, Chambers J, Rosenhek R, Habib G, Lloyd G, Nistri S, Garbi M, Marchetta S, Fattouch K, Coisne A, Montaigne D, Modine T, Davin L, Gach O, Radermecker M, Liu S, Gillam L, Rossi A, Galli E, Ilardi F, Tastet L, Capoulade R, Zilberszac R, Vollema EM, Delgado V, Cosyns B, Lafitte S, Bernard A, Pierard LA, Bax JJ, Pibarot P, Oury C. Outcomes of patients with asymptomatic aortic stenosis followed up in heart valve clinics. JAMA Cardiol. 2018;3:1060–8.CrossRef 4, Lancellotti P, Magne J, Dulgheru R, Clavel MA, Donal E, Vannan MA, Chambers J, Rosenhek R, Habib G, Lloyd G, Nistri S, Garbi M, Marchetta S, Fattouch K, Coisne A, Montaigne D, Modine T, Davin L, Gach O, Radermecker M, Liu S, Gillam L, Rossi A, Galli E, Ilardi F, Tastet L, Capoulade R, Zilberszac R, Vollema EM, Delgado V, Cosyns B, Lafitte S, Bernard A, Pierard LA, Bax JJ, Pibarot P, Oury C. Outcomes of patients with asymptomatic aortic stenosis followed up in heart valve clinics. JAMA Cardiol. 2018;3:1060–8.CrossRef
5.
go back to reference Bahler RC, Hawi R, Rovner A, Finkelhor RS, Thomas CL, Dawson NV. Predicting outcomes in patients with asymptomaticmoderate to severe aortic stenosis. Am J Cardiol. 2018;122:851–8.CrossRef Bahler RC, Hawi R, Rovner A, Finkelhor RS, Thomas CL, Dawson NV. Predicting outcomes in patients with asymptomaticmoderate to severe aortic stenosis. Am J Cardiol. 2018;122:851–8.CrossRef
6.
go back to reference Yechoor P, Blaustein AS, Bakaeen FG, Cornwell LD, Coselli JS, LeMaire SA, Chu D. The natural history of moderate aortic stenosis in a veteran population. J Thoracic Cardiovasc Surg. 2013;145:1550–3.CrossRef Yechoor P, Blaustein AS, Bakaeen FG, Cornwell LD, Coselli JS, LeMaire SA, Chu D. The natural history of moderate aortic stenosis in a veteran population. J Thoracic Cardiovasc Surg. 2013;145:1550–3.CrossRef
7.
go back to reference Strange G, Stewart S, Celermajer D, Prior D, Scalia GM, Marwick T, Ilton M, Joseph M, Codde J, Playford D. Poor long-term survival in patients with moderate aortic stenosis. J Am Coll Cardiol. 2019;74:1851–63.CrossRef Strange G, Stewart S, Celermajer D, Prior D, Scalia GM, Marwick T, Ilton M, Joseph M, Codde J, Playford D. Poor long-term survival in patients with moderate aortic stenosis. J Am Coll Cardiol. 2019;74:1851–63.CrossRef
8.
go back to reference Delesalle G, Bohbot Y, Rusinaru D, Delpierre Q, Marechaux S, Tribouilloy C. Characteristics and prognosis of patients with moderate aortic stenosis and preserved left ventricular ejection fraction. J Am Heart Assoc. 2019;8:e011036.CrossRef Delesalle G, Bohbot Y, Rusinaru D, Delpierre Q, Marechaux S, Tribouilloy C. Characteristics and prognosis of patients with moderate aortic stenosis and preserved left ventricular ejection fraction. J Am Heart Assoc. 2019;8:e011036.CrossRef
9.
go back to reference van Gils L, Clavel MA, Vollema EM, Hahn RT, Spitzer E, Delgado V, Nazif T, De Jaegere PP, Geleijnse ML, Ben-Yehuda O, Bax JJ, Leon MB, Pibarot P, Van Mieghem NM. Prognostic implications of moderate aortic stenosis in patients with left ventricular systolic dysfunction. J Am Coll Cardiol. 2017;69:2383–92.CrossRef van Gils L, Clavel MA, Vollema EM, Hahn RT, Spitzer E, Delgado V, Nazif T, De Jaegere PP, Geleijnse ML, Ben-Yehuda O, Bax JJ, Leon MB, Pibarot P, Van Mieghem NM. Prognostic implications of moderate aortic stenosis in patients with left ventricular systolic dysfunction. J Am Coll Cardiol. 2017;69:2383–92.CrossRef
10.
go back to reference 10, Baumgartner H, Hung J, Bermejo J, Chambers JB, Edvardsen T, Goldstein S, Lancellotti P, LeFevre M, Miller F Jr, Otto CM. Recommendations on the echocardiographic assessment of aortic valve stenosis: a focused update from the european association of cardiovascular imaging and the american society of echocardiography. J Am Soc Echocardiogr. 2017;30:372–92.CrossRef 10, Baumgartner H, Hung J, Bermejo J, Chambers JB, Edvardsen T, Goldstein S, Lancellotti P, LeFevre M, Miller F Jr, Otto CM. Recommendations on the echocardiographic assessment of aortic valve stenosis: a focused update from the european association of cardiovascular imaging and the american society of echocardiography. J Am Soc Echocardiogr. 2017;30:372–92.CrossRef
11.
go back to reference Saikrishnan N, Kumar G, Sawaya FJ, Lerakis S, Yoganathan AP. Accurate assessment of aortic stenosis: a review of diagnostic modalities and hemodynamics. Circulation. 2014;129:244–53.CrossRef Saikrishnan N, Kumar G, Sawaya FJ, Lerakis S, Yoganathan AP. Accurate assessment of aortic stenosis: a review of diagnostic modalities and hemodynamics. Circulation. 2014;129:244–53.CrossRef
12.
go back to reference Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57:450–8.CrossRef Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57:450–8.CrossRef
13.
go back to reference Niikura H, Gossl M, Kshettry V, Olson S, Sun B, Askew J, Stanberry L, Garberich R, Tang L, Lesser J, Bae R, Harris KM, Bradley SM, Sorajja P. Causes and clinical outcomes of patients who are ineligible for transcatheter mitral valve replacement. JACC Cardiovasc Intervent. 2019;12:196–204.CrossRef Niikura H, Gossl M, Kshettry V, Olson S, Sun B, Askew J, Stanberry L, Garberich R, Tang L, Lesser J, Bae R, Harris KM, Bradley SM, Sorajja P. Causes and clinical outcomes of patients who are ineligible for transcatheter mitral valve replacement. JACC Cardiovasc Intervent. 2019;12:196–204.CrossRef
14.
go back to reference Lindman BR, Alexander KP, O’Gara PT, Afilalo J. Futility, benefit, and transcatheter aortic valve replacement. JACC Cardiovasc Intervent. 2014;7:707–16.CrossRef Lindman BR, Alexander KP, O’Gara PT, Afilalo J. Futility, benefit, and transcatheter aortic valve replacement. JACC Cardiovasc Intervent. 2014;7:707–16.CrossRef
15.
go back to reference Tang L, Gossl M, Ahmed A, Garberich R, Bradley SM, Niikura H, Witt D, Pedersen WR, Bae R, Lesser JR, Harris KM, Sun B, Mudy K, Sorajja P. Contemporary reasons and clinical outcomes for patients with severe, symptomatic aortic stenosis not undergoing aortic valve replacement. Circulation Cardiovasc Intervent. 2018;11:e007220. Tang L, Gossl M, Ahmed A, Garberich R, Bradley SM, Niikura H, Witt D, Pedersen WR, Bae R, Lesser JR, Harris KM, Sun B, Mudy K, Sorajja P. Contemporary reasons and clinical outcomes for patients with severe, symptomatic aortic stenosis not undergoing aortic valve replacement. Circulation Cardiovasc Intervent. 2018;11:e007220.
16.
go back to reference Kappetein AP, Head SJ, Genereux P, Piazza N, van Mieghem NM, Blackstone EH, Brott TG, Cohen DJ, Cutlip DE, van Es GA, Hahn RT, Kirtane AJ, Krucoff MW, Kodali S, Mack MJ, Mehran R, Rodes-Cabau J, Vranckx P, Webb JG, Windecker S, Serruys PW, Leon MB. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol. 2012;60:1438–54.CrossRef Kappetein AP, Head SJ, Genereux P, Piazza N, van Mieghem NM, Blackstone EH, Brott TG, Cohen DJ, Cutlip DE, van Es GA, Hahn RT, Kirtane AJ, Krucoff MW, Kodali S, Mack MJ, Mehran R, Rodes-Cabau J, Vranckx P, Webb JG, Windecker S, Serruys PW, Leon MB. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol. 2012;60:1438–54.CrossRef
17.
go back to reference Leon MB, Piazza N, Nikolsky E, Blackstone EH, Cutlip DE, Kappetein AP, Krucoff MW, Mack M, Mehran R, Miller C, Morel MA, Petersen J, Popma JJ, Takkenberg JJ, Vahanian A, van Es GA, Vranckx P, Webb JG, Windecker S, Serruys PW. Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium. J Am Coll Cardiol. 2011;57:253–69.CrossRef Leon MB, Piazza N, Nikolsky E, Blackstone EH, Cutlip DE, Kappetein AP, Krucoff MW, Mack M, Mehran R, Miller C, Morel MA, Petersen J, Popma JJ, Takkenberg JJ, Vahanian A, van Es GA, Vranckx P, Webb JG, Windecker S, Serruys PW. Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium. J Am Coll Cardiol. 2011;57:253–69.CrossRef
18.
go back to reference Everett RJ, Tastet L, Clavel MA, Chin CWL, Capoulade R, Vassiliou VS, Kwiecinski J, Gomez M, van Beek EJR, White AC, Prasad SK, Larose E, Tuck C, Semple S, Newby DE, Pibarot P, Dweck MR. Progression of hypertrophy and myocardial fibrosis in aortic stenosis: a multicenter cardiac magnetic resonance study. Circul Cardiovasc Imag. 2018;11:e007451. Everett RJ, Tastet L, Clavel MA, Chin CWL, Capoulade R, Vassiliou VS, Kwiecinski J, Gomez M, van Beek EJR, White AC, Prasad SK, Larose E, Tuck C, Semple S, Newby DE, Pibarot P, Dweck MR. Progression of hypertrophy and myocardial fibrosis in aortic stenosis: a multicenter cardiac magnetic resonance study. Circul Cardiovasc Imag. 2018;11:e007451.
19.
go back to reference Vassiliou VS, Perperoglou A, Raphael CE, Joshi S, Malley T, Everett R, Halliday B, Pennell DJ, Dweck MR, Prasad SK. Midwall fibrosis and 5-year outcome in moderate and severe aortic stenosis. J Am Coll Cardiol. 2017;69:1755–6.CrossRef Vassiliou VS, Perperoglou A, Raphael CE, Joshi S, Malley T, Everett R, Halliday B, Pennell DJ, Dweck MR, Prasad SK. Midwall fibrosis and 5-year outcome in moderate and severe aortic stenosis. J Am Coll Cardiol. 2017;69:1755–6.CrossRef
20.
go back to reference Everett RJ, Treibel TA, Fukui M, Lee H, Rigolli M, Singh A, Bijsterveld P, Tastet L, Musa TA, Dobson L, Chin C, Captur G, Om SY, Wiesemann S, Ferreira VM, Piechnik SK, Schulz-Menger J, Schelbert EB, Clavel MA, Newby DE, Myerson SG, Pibarot P, Lee S, Cavalcante JL, Lee SP, McCann GP, Greenwood JP, Moon JC, Dweck MR. Extracellular myocardial volume in patients with aortic stenosis. J Am Coll Cardiol. 2020;75:304–16.CrossRef Everett RJ, Treibel TA, Fukui M, Lee H, Rigolli M, Singh A, Bijsterveld P, Tastet L, Musa TA, Dobson L, Chin C, Captur G, Om SY, Wiesemann S, Ferreira VM, Piechnik SK, Schulz-Menger J, Schelbert EB, Clavel MA, Newby DE, Myerson SG, Pibarot P, Lee S, Cavalcante JL, Lee SP, McCann GP, Greenwood JP, Moon JC, Dweck MR. Extracellular myocardial volume in patients with aortic stenosis. J Am Coll Cardiol. 2020;75:304–16.CrossRef
21.
go back to reference Zhu D, Ito S, Miranda WR, Nkomo VT, Pislaru SV, Villarraga HR, Pellikka PA, Crusan DJ, Oh JK. Left ventricular global longitudinal strain is associated with long-term outcomes in moderate aortic stenosis. Circul Cardiovasc Imag. 2020;13:e009958. Zhu D, Ito S, Miranda WR, Nkomo VT, Pislaru SV, Villarraga HR, Pellikka PA, Crusan DJ, Oh JK. Left ventricular global longitudinal strain is associated with long-term outcomes in moderate aortic stenosis. Circul Cardiovasc Imag. 2020;13:e009958.
22.
go back to reference Hayward C, Thornton G, Asher A, Tyebally S, Ray-Chaudhuri A, Mangan C, Mouyis K, Harvey G, Saheecha S, Liu S, Singhal A, Karia N, Patel K, Lloyd G, Bhattacharyya S. Determinants of outcome in patients with left ventricular impairment and moderate aortic stenosis. JACC Cardiovasc Imag. 2020;13:1449–50.CrossRef Hayward C, Thornton G, Asher A, Tyebally S, Ray-Chaudhuri A, Mangan C, Mouyis K, Harvey G, Saheecha S, Liu S, Singhal A, Karia N, Patel K, Lloyd G, Bhattacharyya S. Determinants of outcome in patients with left ventricular impairment and moderate aortic stenosis. JACC Cardiovasc Imag. 2020;13:1449–50.CrossRef
23.
go back to reference Schreuder MBB, Daemen JJ, Van Mieghem JNM. Hemodynamic effects of transcatheter aortic valve replacement for moderate aortic stenosis with reduced left ventricular ejection fraction. JACC Cardiovasc Intervent. 2019;12:684–6.CrossRef Schreuder MBB, Daemen JJ, Van Mieghem JNM. Hemodynamic effects of transcatheter aortic valve replacement for moderate aortic stenosis with reduced left ventricular ejection fraction. JACC Cardiovasc Intervent. 2019;12:684–6.CrossRef
24.
go back to reference Samad Z, Vora AN, Dunning A, Schulte PJ, Shaw LK, Al-Enezi F, Ersboll M, McGarrah RW 3rd, Vavalle JP, Shah SH, Kisslo J, Glower D, Harrison JK, Velazquez EJ. Aortic valve surgery and survival in patients with moderate or severe aortic stenosis and left ventricular dysfunction. Eur Heart J. 2016;37:2276–86.CrossRef Samad Z, Vora AN, Dunning A, Schulte PJ, Shaw LK, Al-Enezi F, Ersboll M, McGarrah RW 3rd, Vavalle JP, Shah SH, Kisslo J, Glower D, Harrison JK, Velazquez EJ. Aortic valve surgery and survival in patients with moderate or severe aortic stenosis and left ventricular dysfunction. Eur Heart J. 2016;37:2276–86.CrossRef
25.
go back to reference Chau KH, Douglas PS, Pibarot P, Hahn RT, Khalique OK, Jaber WA, Cremer P, Weissman NJ, Asch FM, Zhang Y, Gertz ZM, Elmariah S, Clavel MA, Thourani VH, Daubert M, Alu MC, Leon MB, Lindman BR. Regression of Left ventricular mass after transcatheter aortic valve replacement: the PARTNER trials and registries. J Am Coll Cardiol. 2020;75:2446–58.CrossRef Chau KH, Douglas PS, Pibarot P, Hahn RT, Khalique OK, Jaber WA, Cremer P, Weissman NJ, Asch FM, Zhang Y, Gertz ZM, Elmariah S, Clavel MA, Thourani VH, Daubert M, Alu MC, Leon MB, Lindman BR. Regression of Left ventricular mass after transcatheter aortic valve replacement: the PARTNER trials and registries. J Am Coll Cardiol. 2020;75:2446–58.CrossRef
26.
go back to reference Eleid MF, Padang R, Pislaru SV, Greason KL, Crestanello J, Nkomo VT, Pellikka PA, Jentzer JC, Gulati R, Sandhu GS, Holmes DR Jr, Nishimura RA, Rihal CS, Borlaug BA. Effect of transcatheter aortic valve replacement on right ventricular-pulmonary artery coupling. JACC Cardiovasc Intervent. 2019;12:2145–54.CrossRef Eleid MF, Padang R, Pislaru SV, Greason KL, Crestanello J, Nkomo VT, Pellikka PA, Jentzer JC, Gulati R, Sandhu GS, Holmes DR Jr, Nishimura RA, Rihal CS, Borlaug BA. Effect of transcatheter aortic valve replacement on right ventricular-pulmonary artery coupling. JACC Cardiovasc Intervent. 2019;12:2145–54.CrossRef
27.
go back to reference Stachon P, Kaier K, Zirlik A, Bothe W, Heidt T, Zehender M, Bode C, von Zur Muhlen C. Risk-adjusted comparison of in-hospital outcomes of transcatheter and surgical aortic valve replacement. J Am Heart Assoc. 2019;8:e011504.CrossRef Stachon P, Kaier K, Zirlik A, Bothe W, Heidt T, Zehender M, Bode C, von Zur Muhlen C. Risk-adjusted comparison of in-hospital outcomes of transcatheter and surgical aortic valve replacement. J Am Heart Assoc. 2019;8:e011504.CrossRef
28.
go back to reference Spitzer E, Van Mieghem NM, Pibarot P, Hahn RT, Kodali S, Maurer MS, Nazif TM, Rodes-Cabau J, Paradis JM, Kappetein AP, Ben-Yehuda O, van Es GA, Kallel F, Anderson WN, Tijssen J, Leon MB. Rationale and design of the transcatheter aortic valve replacement to unload the left ventricle in patients with advanced heart failure (TAVR UNLOAD) trial. Am Heart J. 2016;182:80–8.CrossRef Spitzer E, Van Mieghem NM, Pibarot P, Hahn RT, Kodali S, Maurer MS, Nazif TM, Rodes-Cabau J, Paradis JM, Kappetein AP, Ben-Yehuda O, van Es GA, Kallel F, Anderson WN, Tijssen J, Leon MB. Rationale and design of the transcatheter aortic valve replacement to unload the left ventricle in patients with advanced heart failure (TAVR UNLOAD) trial. Am Heart J. 2016;182:80–8.CrossRef
Metadata
Title
Natural history observations in moderate aortic stenosis
Authors
Yu Du
Mario Gössl
Santiago Garcia
Maurice Enriquez-Sarano
Joao L. Cavalcante
Richard Bae
Go Hashimoto
Miho Fukui
Bernardo Lopes
Aisha Ahmed
Christian Schmidt
Larissa Stanberry
Ross Garberich
Steven M. Bradley
Robert Steffen
Paul Sorajja, MD
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2021
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-021-01901-1

Other articles of this Issue 1/2021

BMC Cardiovascular Disorders 1/2021 Go to the issue